Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists
The cyclic production of estrogen and progesterone by the premenopausal ovary accounts for the steep rise in breast cancer risk in premenopausal women. These hormones are breast cell mitogens. By reducing exposure to these ovarian hormones, agonists of luteinizing hormone-releasing hormone (LHRH) gi...
Guardat en:
| Publicat a: | Breast Cancer Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2000
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138786/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11250719/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr67 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|